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SUI\,IMARY
This thesis contains four sections: overview, methodology in vivo, physiology and
pathology. The first section gives overviews of the contribution of various organs to the
arterial ammonia and of several methods for ammonia determination with their
limitations. The second section deals with ammonia methodology in vivo in blood andior
plasma, in cerebrospinal fluid and in saliva. The third section deals with the physiology of
lactate and ammonia in blood and sweat during exercise. The fourth section deals with
ammonia results in liver disease and during liver transplantation.
A. Overview.
In chapter 1 of the overview, a survey of generation and breakdown of ammonia is given
and estimations are made of the ammonia contributed by various organs to the arterial
blood as well as the removal of ammonia from the arterial blood by the same or other
organs. Contributing organs are - in order of quantitative importance - exercising muscle,
intestines, kidneys and pancreas, and ammonia removing organs are liver, resting muscle,
gut lumen, kidneys, brain, lung and spleen. In the failing liver the metabolism of
ammonia may become impaired and in patients with portal hypertension causing porta-
systemic shunting ammonia delivered by the portal vein may by-pass the liver and arrive
in the systemic circulation.
In chapter 2 of the overview, the various methods for determination of ammonia in blood
and other fluids are discussed and their limitations dealt with. The oldest method - 1859 -
makes use of indophenol in a colorimetric reaction. It is performed on protein-free
supernatant after adjustment o pH 4.0. It has been in use in our laboratory for more than
30 years. This so-called indophenol reaction has been shown to be interfered with a
number of amino acids, also those found in excess in the blood of patients with severe
hepatic failure. Ammonia in serum or plasma can be determined with an enzymatic
method, based on the conversion of 2-oxoglutarate and NIl* to L-glutamate. Other
methods depend on the liberation of ammonia gas and subsequent quantification as NH3-
N. This principle is used in new hand-held devices such as the Blood Ammonia Checker
for whole blood and in the Kodak Ektachem for plasma. The arterial reference values
using various methods all show a range of about 15-40 pmol/I. Owing to liberation of
ammonia resulting from deamination processes, it is senseless to preserve blood or plasma
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at room temperature or at 4 uC (refrigerator). This phenomenon does not take place in the
first 2 weeks when samples are stored deepfrozen at - 20 0C. The anticoagulated (heparin
or EDTA) blood samples should immediately be placed in an ice bath and brought to the
laboratory for analysis. Due to the gaseous nature of ammonia, the determination must be
performed in an ammonia-free surrounding.
B. Methodologl in vivo.
Blood and plasma.
Chapters 3-7 deal with the determination of ammonia in blood and in all chapters (one of)
the methods used was the Blood Ammonia Checker in its earlier (I) or later (II) form.
In chapter 3 the BAC I was compared to an enzymatic method. BAC I was easier, needed
only 20 prl blood and was faster - 16 minutes at the bedside - than the enzymatic method.
The values were slightly lower than those simultaneously performed in plasma with the
enzymatic method. Lack of linearity in the low normal range was a draw-back. In chapter
4 BAC I was compared with both the indophenol reaction (blood) and an eÍrzymatic
method (plasma). When the ammonia content was high, precision was excellent to
satisfactory with any method. In the normal range, only with the BAC I precision was
unsatisfactory, while recovery of added ammonia was unsatisfactory with the indophenol
method. Simultaneous determination of the three methods on arterial blood samples of a
large reference group showed the reference ammonia values to be decreasing in the
following order: indophenol, enzymatic, BAC L BAC I was the most convenient method
in the clinical setting, but the values had to be regarded as semi-quantitative - and as
described in chapter 3 - not linear in the low normal range. A further development was
the BAC II and in chapter 5, the BAC II was tested against an erzymatic method. The
new device had undergone technical improvements and the procedure was speeded up to 4
minutes only, while still 20 pl of blood was needed. There are lower and upper limits to
the method: 7 and 280 pmol/I. The precision of BAC II was excellent and equal to the
enzymatic method, and the recovery of added ammonia likewise was excellent as well as
the linearity. The arterial reference range was 7-28 pmol/I. BAC II combines excellent
methodological results with speed and ease.
As a finger prick delivers enough blood for ammonia determination with the BAC II,
comparisons can be made between capillary and arterial blood ammonia. Capillary blood
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medical-ethical problems in the use of arterial blood. There is a problem with fingertips
however: sweat contains 100 to 200 times as much ammonia as blood and cleansing of the
fingertip grooves has to be done extremely conscientiously in order not to contaminate the
capillary blood. In chapter 6, capillary fingertip BAC II blood ammonia was compared to
simultaneously collected arterial blood BAC II and plasma erzymatic ammonia. There
was a nice correlation between the capillary and arterial ammonia and the capillary
ammonia was higher than the arterial. The arterial BAC II and enzymatic ammonia levels
did not differ. Reproducibility of the fingertip ammonia, tested during 3 consecutive days
in healthy controls, turned out to be poor and despite all the precautions taken, sweat was
considered to be the offender. The difference between capillary and arterial BAC II levels
might have been eliminated when holding the hand in a warm water bath beforehand.
This would have arterialized the capillary blood. Ear-lobe blood might not have the
disadvantages encountered with fingertip blood and in chapter 7 capillary blood samples
from these two sources were tested against each other and against simultaneously drawn
arterial blood using BAC II in a healthy reference group (no arterial determinations), in a
reference group of patients without liver disease and in patients with liver disease. The
ear-lobe levels were not different between the two reference groups and when compared
to the arterial levels showed a small but significant difference in the patients without liver
disease. Both the ear-lobe capillary and arterial blood ammonia ranged within the arterial
ref-erence values published in literature. The fingertip ammonia was uniformly higher than
the ear-lobe ammonia. The overall correlation between ear-lobe and arterial BAC II
ammonia was very good and the conclusion was that ear-lobe capillary blood ammonia is
an alternative for arterial blood ammonia determination.
Cerebrospinal f uid.
In recent years intracranial pressure measurements in some specialized centers has
become a routine procedure in patients with severe hepatic encephalopathy. This allows
an ammonia determination in cerebrospinal fluid. In chapter 8 is described how the
indophenol reaction was used after pH adjustment. Ammonia was determined in a
reference group of patients with neurological disorders, but no liver disease. The recovery
of added ammonia was good. Cerebrospinal fluid could not be stored for ammonia
determination at room temperature, while it could be kept Ïor 2 days at 4 0C in the
refrigerator and for at least 1 month when deepfrozen at - 20 0C. The reference levels
t63
ranged from 8-26 pmol/I.
Saliva.
Saliva is known to have a high ammonia concentration. Until recently, it was not possible
to obtain samples from individual salivary glands. In chapter 9, three methods for
ammonia determination in total saliva were tested: an enzymatic method and the
indophenol reaction on 1:100 diluted specimens and an ammonium electrode. The
ammonium electrode was the quickest procedure but it requires correction for the
potassium content of saliva (which therefore has to be determined as well). The enzymatic
method gave the same result as the electrode but was more expensive. The indophenol
method had both the best precision and the lowest reagent cost. The reference values were
regardless of any method 1-12 mmolil. In chapter 10, the preservation of saliva for
ammonia determination was studied using the three afore mentioned methods. If
immediately diluted and kept at 4 0C ammonia could be reliably measured using any
method if determined within t hour. When saliva was immediately deepfrozen at - 2O oC
the specimen could be kept for more than 2 weeks. As it recently became possible to
sample saliva from individual salivary glands, more insight into the origin of oral cavity
(total saliva) ammonia might be obtained. The results of the ammonia determination with
the indophenol method in saliva from parotid and submandibular/sublingual glands and
total saliva aÍe described in chapter 11. The median ammonia content of total saliva was 8
to 20 times as high as the content of the salivary glands. One possible reason is bacterial
hydrolysis of ureum in the mouth through, e.g. Streptococcus alivarius and Helicobacter
pylori.
C. PhLsiolog)t=
Break-down in the muscle cell during exercise of adenosine 5-monophosphate to inosine
5-monophosphate and ammonia leads to enhanced glycolytic activity with production of
lactate, leading to elevated blood levels of both ammonia and lactate. An endurance
threshold using blood lactate has been proposed. When during exercise sweat ammonia
and lactate would show linear relationships to blood ammonia and lactate, sweat in stead
of blood possibly could be used. In chaper 12 is described how 10 healthy subjects cycled
a workload of at least 200 watt, while ear-lobe capillary blood as well as sweat samples





























































workloads of 225-300 watt to levels seen in patients with hepatic encephalopathy, the
highest value obtained being 227 p"mol NH3-N/I after 325 watt. Blood lactate increased 3-
fold and there was a linear relationship between the ammonia and lactate increases. Sweat
lactate and ammonia both decreased (with a linear relationship) during exercise. The
relationships between blood and sweat ammonia as well as between blood and sweat
lactate were non-linear however and the conclusion was that sweat cannot replace blood
for lactate and ammonia measurement to determine endurance capacity.
D. Pathology.
Chapter 13 and 14 deal with the usefulness of determining arterial ammonia in patients
with liver disease.
In chapter 13, we investigated three ammonia methods in liver patients without overt
encephalopathy and compared them with control patients. The three methods were the
enzymatrc method in plasma and in whole blood the indophenol method and the Blood
Ammonia Checker (BAC) I, all in arterial samples in the fasting patient. There were 106
non-encephalopathic liver patients,56 with and 50 without cirrhotic and 51 controls
(patients without liver disease). Patients with cirrhosis had higher ammonia levels with the
enzymatic method and with BAC I than the non-cirrhotic and control group, and in
addition the enzymatic method separated the non-cirrhotics from the control groups. The
indophenol method could not discriminate liver patients from the control group.
While in chapter 13 liver patients with overt encephalopathy were excluded, in chapter 14
arterial ammonia was determined using the BAC II and indophenol method in liver
patients with (70) and without (55) overt hepatic encephalopathy (HE) and compared with
the findings in 39 patients without liver disease and 13 patients with neurological
encephalopathy, without liver disease. We had observed earlier that in patients with
severe hepatic failure the indophenol reaction could become depressed and even totaly
inhibited and an in vitro study had shown that this interference was due to a number of
(aromatic) amino acids, which may be found in excess in blood of liver encephalopathy
patients. The difference between BAC II ammonia and indophenol ammonia was regarded
to express this interference of the indophenol reaction (IFI) and was expressed in prmol -
N/1. While in the control groups differences between BAC II and indophenol ammonia
were small or absent, in liver patients indophenol ammonia lagged behind BAC II
ammonia, and IFI increased with increasing BAC, which supposedly means an increase of
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indophenol inhibiting amino acids. BAC II was effective in discriminating hepatic
encephalopathy from neurological encephalopathy. As in the earlier investigation,
indophenol ammonia showed no difference between the control group and liver patients.
Using the two methods and IFI there was a difference between patients with and patients
without overt hepatic encephalopathy.
In chapter 15, the ammonia concentrations during four episodes of the orthotopic liver
transplantation (OLT) operation procedure are presented. Ammonia was determined in 17
OLT patients using the indophenol method during: donor announcement (I), operation
until hepatectomy completed (II), anhepatic phase (III) and t h after implantation with
restored blood circulation (IV). For reÍ'erence a group of 16 patients without liver disease
was used. The ammonia concentrations in stage I, II and III were higher and ammonia's
in stage IV did not differ from the reference group. Within I h after implantation of the
new liver and with restored blood circulation, the arterial blood ammonia refurned to
normal. In a longitudinal analysis, ammonia concentration in stage III was higher and in
stage IV lower than in stages I and II. Conservation of the urea cycle is critical with
regard to the vitality of the liver, and ammonia determination before the OLT operation
and directly after recirculation can give insight in the eliminative power and function of
the new liver.
CONCLUSIONS
Determination of ammonia in biological fluids need different methodology. For whole
blood the Blood Ammonia Checker II is an improvement over other methods, also
because it can be performed in ear-lobe capillary blood, which accurately reflects the
arterial blood ammonia concentration. For other biological fluids - biological and non-
biological - the indophenol reaction is both easy and effective, and in arterial plasma or
serum the enzymatic method is excellent.
Although hepatic encephalopathy (HE) easily can be discriminated from non-liver diseases
and from other encephalopathy, a more precise definition of liver patients without HE,
with subclinical HE and with overt HE will enhance the usefulness of the blood ammonia
determination. The fact that very high ammonia levels - compatible with severe HE -
occur after a heavy workload in healthy persons, will not give rise to confusion as HE






































usefulness of physiological alongside clinico-pathological studies. The interference by a
number of amino acids, notably those incriminated in the pathogenesis of HE due to
severe hepatic failure, is an interesting by-product of Berthelots indophenol ammonia
method of 1859, which however need quantitative amino acid determination in vivo to
establish its true clinical value. The accumulation of ammonia in the liverless state,
leading to elevated blood levels, is understandable and well known, but even more
interesting is the extremely rapid normalisation of the ammonia levels during liver
transplantation by the newly implanted liver, indicating the well-functioning of one of its
most vital functions, deposition of waste ammonia by means of the urea cycle.
